21922-027 NDC - CLINDAMYCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE GEL USP, 1%)

Drug Information

Product NDC: 21922-027

Proprietary Name: Clindamycin Phosphate

Non Proprietary Name: Clindamycin Phosphate Gel USP, 1%

Active Ingredient(s):
  • 10 mg/g CLINDAMYCIN PHOSPHATE


Administration Route(s): TOPICAL

Dosage Form(s): GEL

Pharmacy Class(es):
  • Decreased Sebaceous Gland Activity [PE];
  • Lincosamide Antibacterial [EPC];
  • Lincosamides [CS]

Labeler Information

Labeler Name: Encube Ethicals Private Limited
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA212438
Marketing Category: ANDA
Start Marketing Date:1/13/2020

Package Information

No. Package Code Package Description Billing Unit
121922-027-051 TUBE in 1 CARTON (21922-027-05) > 30 g in 1 TUBEGM
221922-027-071 TUBE in 1 CARTON (21922-027-07) > 60 g in 1 TUBEGM

NDC Record

Field Name Field Value Definition
PRODUCT NDC21922-027The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEClindamycin PhosphateThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEClindamycin Phosphate Gel USP, 1%The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMEGELThe translation of the dosage form Code submitted by the firm.
ROUTE NAMETOPICALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE1/13/2020This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEANDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERANDA212438This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEEncube Ethicals Private LimitedName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMECLINDAMYCIN PHOSPHATEThis is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH10 
ACTIVE INGRED UNITmg/g 
PHARM CLASSESDecreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 6/22/2021